Crossmark Global Holdings, Inc. Calliditas Therapeutics Ab Transaction History
Crossmark Global Holdings, Inc.
- $5.61 Billion
- Q3 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 16,117 shares of CALT stock, worth $644,680. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,117Holding current value
$644,680% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CALT
# of Institutions
23Shares Held
843KCall Options Held
8.5KPut Options Held
26.6K-
Bvf Inc San Francisco, CA750KShares$30 Million0.89% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.6KShares$1.03 Million0.56% of portfolio
-
Optiver Holding B.V. Amsterdam, P722.3KShares$893,4400.02% of portfolio
-
Ubs Group Ag10.8KShares$430,2400.0% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16KShares$240,0000.2% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...